fotemustine has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dargenio, M; Di Renzo, N; Forese, P; Matera, R; Pennese, E; Vergine, C | 1 |
1 other study(ies) available for fotemustine and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
Complete response induced by fotemustine given as single agent in a patient with primary central nervous system non-Hodgkin aggressive lymphoma relapsed after high-dose chemotherapy and autologous stem cell support.
Topics: Adult; Antineoplastic Agents; Central Nervous System Neoplasms; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Therapy; Humans; Lymphoma, Non-Hodgkin; Male; Nitrosourea Compounds; Organophosphorus Compounds; Recurrence; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome | 2011 |